产品标题 产品货号 产品规格 厂家
Human DNA: Breast; Adenocarcinoma of breast, lobular from ORIGENE TECHNOLOGIESCD5632565 ugORIGENE TECHNOLOGIES
Human DNA: Breast; Adenocarcinoma of breast, lobular from ORIGENE TECHNOLOGIESCD5635735 ugORIGENE TECHNOLOGIES
Human DNA: Breast; Adenocarcinoma of breast, lobular from ORIGENE TECHNOLOGIESCD5632835 ugORIGENE TECHNOLOGIES
Human DNA: Breast; Adenocarcinoma of breast, lobular from ORIGENE TECHNOLOGIESCD5637385 ugORIGENE TECHNOLOGIES
Human DNA: Breast; Adenocarcinoma of breast, lobular from ORIGENE TECHNOLOGIESCD5641035 ugORIGENE TECHNOLOGIES
Human DNA: Breast; Adenocarcinoma of breast, lobular from ORIGENE TECHNOLOGIESCD5643485 ugORIGENE TECHNOLOGIES
Human DNA: Breast; Adenocarcinoma of breast, lobular from ORIGENE TECHNOLOGIESCD5643495 ugORIGENE TECHNOLOGIES
Human DNA: Breast; Adenocarcinoma of breast, lobular from ORIGENE TECHNOLOGIESCD5645555 ugORIGENE TECHNOLOGIES
Human DNA: Breast; Adenocarcinoma of breast, lobular from ORIGENE TECHNOLOGIESCD5646715 ugORIGENE TECHNOLOGIES
Human DNA: Breast; Adenocarcinoma of breast, lobular from ORIGENE TECHNOLOGIESCD5647165 ugORIGENE TECHNOLOGIES
Human DNA: Breast; Adenocarcinoma of breast, lobular from ORIGENE TECHNOLOGIESCD5649165 ugORIGENE TECHNOLOGIES
Human DNA: Breast; Adenocarcinoma of breast, lobular from ORIGENE TECHNOLOGIESCD5650055 ugORIGENE TECHNOLOGIES
Human DNA: Breast; Adenocarcinoma of breast, lobular from ORIGENE TECHNOLOGIESCD5646485 ugORIGENE TECHNOLOGIES
Human DNA: Breast; Adenocarcinoma of breast, lobular from ORIGENE TECHNOLOGIESCD5651395 ugORIGENE TECHNOLOGIES
Human DNA: Breast-Adenocarcinoma of breast, lobular from ORIGENE TECHNOLOGIESCD565917n/aORIGENE TECHNOLOGIES
Human DNA: Breast; Adenocarcinoma of breast, metaplastic, recurrent from ORIGENE TECHNOLOGIESCD5652095 ugORIGENE TECHNOLOGIES
Human DNA: Breast; Adenocarcinoma of breast, metastatic from ORIGENE TECHNOLOGIESCD5643275 ugORIGENE TECHNOLOGIES
Human DNA: Breast; Adenocarcinoma of breast, metastatic from ORIGENE TECHNOLOGIESCD5648135 ugORIGENE TECHNOLOGIES
Human DNA: Breast; Adenosis of breast, sclerosing from ORIGENE TECHNOLOGIESCD5640805 ugORIGENE TECHNOLOGIES
Human DNA: Breast; Adenosis of breast, sclerosing from ORIGENE TECHNOLOGIESCD5650065 ugORIGENE TECHNOLOGIES
Human DNA: Breast; Carcinoma in situ of breast, ductal, cribriform, solid from ORIGENE TECHNOLOGIESCD5634215 ugORIGENE TECHNOLOGIES
Human DNA: Breast; Adenocarcinoma of breast, micropapillary from ORIGENE TECHNOLOGIESCD5635885 ugORIGENE TECHNOLOGIES
Human DNA: Breast; Ductal hyperplasia of breast from ORIGENE TECHNOLOGIESCD5647175 ugORIGENE TECHNOLOGIES
Human DNA: Breast; Fibrocystic breast disease from ORIGENE TECHNOLOGIESCD5631945 ugORIGENE TECHNOLOGIES
Human DNA: Breast; Fibrocystic breast disease from ORIGENE TECHNOLOGIESCD5644685 ugORIGENE TECHNOLOGIES
Human DNA: Breast; Fibrocystic breast disease from ORIGENE TECHNOLOGIESCD5639975 ugORIGENE TECHNOLOGIES
Human DNA: Breast; Fibrocystic breast disease from ORIGENE TECHNOLOGIESCD5645745 ugORIGENE TECHNOLOGIES
Human DNA: Breast; Fibrocystic changes of breast, atypical from ORIGENE TECHNOLOGIESCD5636075 ugORIGENE TECHNOLOGIES
Human DNA: Breast; Fibrocystic breast disease from ORIGENE TECHNOLOGIESCD5647295 ugORIGENE TECHNOLOGIES
Human DNA: Breast; Fibrocystic breast disease from ORIGENE TECHNOLOGIESCD5647995 ugORIGENE TECHNOLOGIES
Human STEAP family member 4 (STEAP4) from ORIGENE TECHNOLOGIESTP31691720 ugORIGENE TECHNOLOGIES
Human STEAP family member 3 (STEAP3), transcript variant 2 from ORIGENE TECHNOLOGIESTP32427420 ugORIGENE TECHNOLOGIES
Human STEAP family member 3 (STEAP3), transcript variant 3 from ORIGENE TECHNOLOGIESTP31059520 ugORIGENE TECHNOLOGIES
BCMA/TNFRSF17 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN2088511 kitORIGENE TECHNOLOGIES
BCMA/TNFRSF17 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN208851BN1 kitORIGENE TECHNOLOGIES
BCMA/TNFRSF17 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN208851LP1 kitORIGENE TECHNOLOGIES
BCMA/TNFRSF17 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN208851RB1 kitORIGENE TECHNOLOGIES
BCMA/TNFRSF17 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4088511 kitORIGENE TECHNOLOGIES
BCMA/TNFRSF17 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5179801 kitORIGENE TECHNOLOGIES
BCMO1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4237901 kitORIGENE TECHNOLOGIES
Bcmo1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5021181 kitORIGENE TECHNOLOGIES
BCMO1 Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH32379010 ugORIGENE TECHNOLOGIES
BCO2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4186351 kitORIGENE TECHNOLOGIES
Complement component 2 (C2), transcript variant 1 from ORIGENE TECHNOLOGIESLY400024100 ugORIGENE TECHNOLOGIES
Complement component 2 (C2), transcript variant 2 from ORIGENE TECHNOLOGIESLY429041100 ugORIGENE TECHNOLOGIES
Complement component 6 (C6), transcript variant 1 from ORIGENE TECHNOLOGIESLY400016100 ugORIGENE TECHNOLOGIES
Complement component 6 (C6), transcript variant 2 from ORIGENE TECHNOLOGIESLY426524100 ugORIGENE TECHNOLOGIES
Complement component (3d/Epstein Barr virus) receptor 2 (CR2), transcript variant 2 from ORIGENE TECHNOLOGIESLY419676100 ugORIGENE TECHNOLOGIES
Complement component 8, gamma polypeptide (C8G) from ORIGENE TECHNOLOGIESLY424611100 ugORIGENE TECHNOLOGIES
Human macrophage scavenger receptor 1 (MSR1), transcript variant SR-AII from ORIGENE TECHNOLOGIESTP31293120 ugORIGENE TECHNOLOGIES
 |< < 5104 5105 5106 5107 5108 5109 5110 5111 5112 > >| 第 5106/6274 页